Glad ALIM had a good move today. When the Iluvien approval is final on Friday or Monday, which company really has the upside? Alimera may be a two to three trick pony. It will however help many people and generate significant revenue. PSDV, on the flip side, will start generating interest from other company's to deliver "THEIR" drugs. Every application going forward means; 1). licensing fees and profit sharing agreements. 2). licensing fees and profit sharing agreements. 3). licensing agreements and profit sharing agreements.
Much of the ground work has been done in this company. Now it's which drug in what place, to aid and assist in what ailment....we already know who's going to pay and how PSDV will profit. Humanity benefits..It won't hurt the true longs either. Save some shares through the pop.
I know you didn't ask me, but I'll butt in and comment on the CC. No surprises, but the CEO's answers to the two questions (basically the same question) about the survey and its relation to approval were weak-sounding. Not actually weak, since ALIM had provided all of the clarity on Friday. But I wish the CEO would have just firmly said, (1) we are not privy to this info since Alimera is in contact with the FDA (they did say that) and (2) even if we did, we couldn't comment further than Alimera already has. And by the way, here is what ALIM said... quoting Alimera. ALIM's CC was very direct, confident, and stated clearly what they COULDN'T say. pSivida was a bit wishy washy and sounded less than confident.
ALIM's call was clear. It didn't give us significantly more information, it just sounded better. PSDV would have been well served just quoting it, rather than pointing to it in a hedging way. Maybe PSDV didn't want to be on the hook for the confidence that ALIM expressed Friday.
It seems as though everybody knows they can't answer questions this close to the PDUFA date, and everybody is in wait-and-see mode anyway. Nothing in the content of the answers today shakes anything that ALIM said on Friday, so if one was confident then, one should be confident now, I would think. The manner of the response, though, was less than confidence-inspiring.
Brainy, I did listen. It still doesn't explain the Friday dip. Like so many say "sell first and ask questions later". Earnings beat. Revenues up 249%, year/year. Gee, do think that's likely to go up? Up is good....right?